Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and Genetic Markers of Vascular Toxicity in Glioblastoma Patients: Insights from NRG Oncology RTOG-0825.
Strauss JD, Gilbert MR, Mehta M, Li A, Ms RZ, Bondy ML, Sulman EP, Yuan Y, Liu Y, Vera E, Wendland MM, Stieber VW, Puduvalli VK, Choi S, Martinez NL, Robins HI, Hunter GK, Lin CF, Guedes VA, Richard MA, Pugh SL, Armstrong TS, Scheurer ME. Strauss JD, et al. Among authors: wendland mm. Neuro Oncol. 2024 Nov 16:noae234. doi: 10.1093/neuonc/noae234. Online ahead of print. Neuro Oncol. 2024. PMID: 39549280
Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.
Scheurer ME, Zhou R, Gilbert MR, Bondy ML, Sulman EP, Yuan Y, Liu Y, Vera E, Wendland MM, Youssef EF, Stieber VW, Komaki RR, Flickinger JC, Kenyon LC, Robins HI, Hunter GK, Crocker IR, Chao ST, Pugh SL, Armstrong TS. Scheurer ME, et al. Among authors: wendland mm. Neurooncol Adv. 2022 Oct 22;4(1):vdac152. doi: 10.1093/noajnl/vdac152. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36299794 Free PMC article.
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
Patil N, Somasundaram E, Waite KA, Lathia JD, Machtay M, Gilbert MR, Connor JR, Rubin JB, Berens ME, Buerki RA, Choi S, Sloan AE, Penas-Prado M, Ashby LS, Blumenthal DT, Werner-Wasik M, Hunter GK, Flickinger JC, Wendland MM, Panet-Raymond V, Robins HI, Pugh SL, Mehta MP, Barnholtz-Sloan JS. Patil N, et al. Among authors: wendland mm. J Neurooncol. 2021 Dec;155(3):363-372. doi: 10.1007/s11060-021-03886-5. Epub 2021 Nov 10. J Neurooncol. 2021. PMID: 34761331 Free PMC article.
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825).
Wefel JS, Armstrong TS, Pugh SL, Gilbert MR, Wendland MM, Brachman DG, Roof KS, Brown PD, Crocker IR, Robins HI, Hunter G, Won M, Mehta MP. Wefel JS, et al. Among authors: wendland mm. Neuro Oncol. 2021 Jul 1;23(7):1125-1138. doi: 10.1093/neuonc/noab011. Neuro Oncol. 2021. PMID: 33515019 Free PMC article. Clinical Trial.
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.
Lee EQ, Zhang P, Wen PY, Gerstner ER, Reardon DA, Aldape KD, deGroot JF, Pan E, Raizer JJ, Kim LJ, Chmura SJ, Robins HI, Connelly JM, Battiste JD, Villano JL, Wagle N, Merrell RT, Wendland MM, Mehta MP. Lee EQ, et al. Among authors: wendland mm. Cancer. 2020 Jun 15;126(12):2821-2828. doi: 10.1002/cncr.32811. Epub 2020 Mar 10. Cancer. 2020. PMID: 32154928 Free PMC article. Clinical Trial.
20 results